Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-12 |
mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-12 |
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.23 | 8e-11 |
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-10 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-08 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-08 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.16 | 8e-07 |
mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-06 |
mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-06 |